Effect of the G-308A polymorphism of the tumor necrosis factor (TNF)-α gene promoter site on plasma levels of TNF-α and C-reactive protein in smokers: a cross-sectional study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ross R: Atherosclerosis – an inflammatory disease. N Engl J Med. 1999, 340: 115-126. 10.1056/NEJM199901143400207.
Schreyer SA, Peschon JJ, LeBoeuf RC: Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J Biol Chem. 1996, 271: 26174-26178. 10.1074/jbc.271.42.26174.
Rader DJ: Inflammatory markers of coronary risk. N Engl J Med. 2000, 343: 1179-1182. 10.1056/NEJM200010193431609.
Torzewski J, Torzewski M, Bowyer DE, Frohlich M, Koenig W, Waltenberger J, Fitzsimmons C, Hombach V: C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol. 1998, 18: 1386-1392.
Clausell N, Kalil P, Biolo A, Molossi S, Azevedo M: Increased expression of tumor necrosis factor-alpha in diabetic macrovasculopathy. Cardiovasc Pathol. 1999, 8: 145-151. 10.1016/S1054-8807(98)00033-7.
Koenig W: Inflammation and coronary heart disease: an overview. Cardiol Rev. 2001, 9: 31-35. 10.1097/00045415-200101000-00007.
Plutzky J: Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol. 2001, 88: 10K-15K. 10.1016/S0002-9149(01)01924-5.
Gensini GF, Comeglio M, Colella A: Classical risk factors and emerging elements inthe risk profile for coronary artery disease. Eur Heart J. 1998, 19 (Suppl A): A53-A61.
Tappia PS, Troughton KL, Langley-Evans SC, Grimble RF: Cigarette smoking influences cytokine production and antioxidant defences. Clin Sci. 1995, 88: 485-459.
de Maat MP, Pietersma A, Kofflard M, Sluiter W, Kluft C: Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers. Atherosclerosis. 1996, 121: 185-191. 10.1016/0021-9150(95)05716-1.
Sonmez K, Akcay A, Akcakoyun M, Demir D, Elonu OH, Pala S, Duran NE, Gencbay M, Degertekin M, Turan F: Distribution of risk factors and prophylactic drug usage in Turkish patients with angiographically established coronary artery disease. J Cardiovasc Risk. 2002, 9: 199-205. 10.1097/00043798-200208000-00004.
Talmud PJ, Hawe E, Miller GJ: Analysis of gene-environment interaction in coronary artery disease: lipoprotein lipase and smoking as examples. Ital Heart J. 2002, 3: 6-9.
Risley P, Jerrard-Dunne P, Sitzer M, Buehler A, von Kegler S, Markus HS: Promoter polymorphism in the endotoxin receptor (CD14) is associated with increased carotid atherosclerosis only in smokers: the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 2003, 34: 600-604. 10.1161/01.STR.0000055941.61801.5A.
Ortlepp JR, Metrikat J, Vesper K, Mevissen V, Schmitz F, Albrecht M, Maya-Pelzer P, Hanrath P, Weber C, Zerres K, Hoffmann R: The interleukin-6 promoter polymorphism is associated with elevated leukocyte, lymphocyte, and monocyte counts and reduced physical fitness in young healthy smokers. J Mol Med. 2003, 81: 578-584. 10.1007/s00109-003-0471-6.
Wilson AG, di Giovine FS, Blakemore AI, Duff GW: Single base polymorphism in the human tumor necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet. 1992, 1: 353-
Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 1997, 94: 3195-3199. 10.1073/pnas.94.7.3195.
Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, Mahieu P, Malaise M, De Groote D, Louis R, Belaiche J: Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS) stimulated whole blood cell culture in healthy humans. Clin Exp Immunol. 1998, 113: 401-406. 10.1046/j.1365-2249.1998.00662.x.
Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, Ruidavets JB, Luc G, Bara L, Parra HJ, Poirier O, Cambien F: Polymorphisms of the tumour necrosis factor alpha gene, coronary heart disease and obesity. Eur J Clin Invest. 1998, 28: 59-66. 10.1046/j.1365-2362.1998.00244.x.
Padovani JC, Pazin-Filho A, Simoes MV, Marin-Neto JA, Zago MA, Franco RF: Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res. 2000, 100: 263-269. 10.1016/S0049-3848(00)00315-7.
Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND, Jeffery S, Kaski JC, Cumberland DC, Duff GW, Crossman DC: Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation. 1999, 99: 861-866.
Keso T, Perola M, Laippala P, Ilveskoski E, Kunnas TA, Mikkelsson J, Penttila A, Hurme M, Karhunen PJ: Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis. 2001, 154: 691-697. 10.1016/S0021-9150(00)00602-X.
Densem CG, Hutchinson IV, Yonan N, Brooks NH: Influence of tumor necrosis factor alpha gene-308 polymorphism on the development of coronary vasculopathy after cardiac transplantation. J Heart Lung Transplant. 2001, 20: 1265-1273. 10.1016/S1053-2498(01)00358-8.
Allen RA, Lee EM, Roberts DH, Park BK, Pirmohamed M: Polymorphisms in the TNF alpha and TNF-receptor genes in patients with coronary artery disease. Eur J Clin Invest. 2001, 31: 843-851. 10.1046/j.1365-2362.2001.00907.x.
Koch W, Kastrati A, Bottiger C, Mehilli J, von Beckerath N, Schomig A: Interleukin 10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis. 2001, 159: 137-144. 10.1016/S0021-9150(01)00467-1.
Wu AH, Tsongalis GJ: Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. Am J Cardiol. 2001, 87: 1361-1366. 10.1016/S0002-9149(01)01553-3.
Wang XL, Rainwater DL, VandeBerg JF, Mitchell BD, Mahaney MC: Genetic contributions to plasma total antioxidant activity. Arterioscler Thromb Vasc Biol. 2001, 21: 1190-1195.
Vischetti M, Zito F, Donati MB, Iacoviello L: Analysis of gene-environment interaction in coronary heart disease: fibrinogen polymorphisms as an example. Ital Heart J. 2002, 3: 18-23.
Michael YL, Colditz GA, Coakley E, Kawachi I: Health behaviors, social networks, and healthy aging: cross-sectional evidence from the Nurses' Health Study. Qual Life Res. 1999, 8: 711-722. 10.1023/A:1008949428041.
Jonsson D, Rosengren A, Dotevall A, Lappas G, Wilhelmsen L: Job control, job demands and social support at work in relation to cardiovascular riskfactors in MONICA 1995, Goteborg. J Cardiovasc Risk. 1999, 6: 379-385.
Ridker PM, Haughie P: Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. J Investig Med. 1998, 46: 391-395.
Rifai N, Ridker PM: High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem. 2001, 47: 403-411.
Little R, Stroup WC, Freund RJ: SAS for linear models. 2002, Cary, NC: SAS Institute Inc, 4
Jomini V, Oppliger-Pasquali S, Wietlisbach V, Rodondi N, Jotterand V, Paccaud F, Darioli R, Nicod P, Mooser V: Contribution of major cardiovascular risk factors to familial premature coronary artery disease: the GENECARD project. J Am Coll Cardiol. 2002, 40: 676-684. 10.1016/S0735-1097(02)02017-X.
Black PH, Garbutt LD: Stress, inflammation and cardiovascular disease. J Psychosom Res. 2002, 52: 1-23. 10.1016/S0022-3999(01)00302-6.
Berenson GS, Srinivasan SR, Bao W: Precursors of cardiovascular risk in young adults from a biracial (black-white) population: the Bogalusa Heart Study. Ann N Y Acad Sci. 1997, 817: 189-198.
Pesonen E: Infection and intimal thickening: evidence from coronary arteries in children. Eur Heart J. 1994, 15 (Suppl C): 57-61.
Andreotti F, Porto I, Crea F, Maseri A: Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart. 2002, 87: 107-112. 10.1136/heart.87.2.107.
Hajeer AH, Hutchinson IV: TNF-alpha gene polymorphism: clinical and biological implications. Microsc Res Tech. 2000, 50: 216-228. 10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.3.CO;2-H.
Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E: Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000, 101: 2149-2153.